The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations
Open accessAbstract
OBJECTIVE: To prospectively monitor inflammatory activity over a prolonged period in a cohort of Turkish patients with FMF, their healthy relatives and healthy controls and to relate this to their MEFV genotypes. METHODS: 43 patients with FMF and 75 of their asymptomatic relatives underwent fortnightly assessments and venesection for measurement of CRP and SAA over 5 months. 50 unrelated healthy population matched controls were also studied. MEFV genotyping was performed on all participants and comparisons were made between the different groups. RESULTS: Paired MEFV mutations were detected in 84% of FMF patients and single mutations in 12%. Substantial acute phase reactivity was seen among the patients with FMF during attacks (median SAA 693 mg/l, CRP 115 mg/l). Between attacks there was also some inflammatory activity (median SAA 6 mg/l, CRP 4 mg/l). Among healthy controls 16% were heterozygotes for MEFV mutations and 4% had two mutations. As expected there was a substantial carrier rate among healthy relatives with mutations detected in almost 92%. Asymptomatic MEFV heterozygotes had elevated acute phase proteins compared to wild type subjects. CONCLUSION: Substantial sub-clinical inflammation occurs widely and over prolonged periods in patients with FMF, indicating that the relatively infrequent clinically overt attacks represent the 'tip of the iceberg' in this disorder. Both basal and peak acute phase protein concentrations were greater in MEFV heterozygotes than in wild-type controls, regardless of mutation demonstrating a 'pro-inflammatory' phenotype among FMF carriers. Upregulation of the acute phase response among carriers of FMF may augment their innate host response and contribute to better resistance to infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Danesh, J., Wheeler, J. G., Hirschfield, G. M., Eda, S., Eiriksdottir, G., Rumley, A., Lowe, G. D. O., Pepys, M. B., & Gudnason, V. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032804 · Cited by 2,953
Criteria for the diagnosis of familial mediterranean fever
Livneh, A., Langevitz, P., Zemer, D., Zaks, N., Kees, S., Lidar, T., Migdal, A., Padeh, S., & Pras, M. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780401023 · Cited by 1,588
A candidate gene for familial Mediterranean fever
The French FMF Consortium, Bernot, A., Clepet, C., Dasilva, C., Devaud, C., Petit, J.-L., Caloustian, C., Cruaud, C., Samson, D., Pulcini, F., et al. (1997) · Nature Genetics · doi:10.1038/ng0997-25 · Cited by 1,558
The International FMF Consortium (1997) · Cell · doi:10.1016/s0092-8674(00)80539-5 · Cited by 1,543
Familial Mediterranean Fever (FMF) in Turkey
Turkish FMF Study Group (2005) · Medicine · doi:10.1097/01.md.0000152370.84628.0c · Cited by 765
Ben‐Chetrit, E., & Levy, M. (1998) · The Lancet · doi:10.1016/s0140-6736(97)09408-7 · Cited by 751
Zaks, N., Balow, J., Mansfield, E. S., Mangelsdorf, M., Shohat, M., Blake, T. B., Gumucio, D. L., Orsborn, A., Shafran, N., Baxevanis, A., et al. (1997) · Cell · Cited by 663
The characterization of soluble amyloid prepared in water
Schubert, M. P., Zucker-Franklin, D., Rimon, A., & Franklin, E. C. (1968) · Journal of Clinical Investigation · doi:10.1172/jci105784 · Cited by 646
The spectrum of Familial Mediterranean Fever (FMF) mutations
Touitou, I. (2001) · European Journal of Human Genetics · doi:10.1038/sj.ejhg.5200658 · Cited by 554
WHO Expert Committee on Biological Standardization.
Horowitz, B., Minor, P., Jj, M., Burnouf, T., McIntosh, R., Padilla, A., Thorpe, R., & van Aken, W. G. (1994) · PubMed · Cited by 534
Cited by
Horror Autoinflammaticus: The Molecular Pathophysiology of Autoinflammatory Disease
Masters, S. L., Simon, A., Aksentijevich, I., & Kastner, D. L. (2009) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141627 · Cited by 1,065
Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS
Park, Y. H., Wood, G., Kastner, D. L., & Chae, J. J. (2016) · Nature Immunology · doi:10.1038/ni.3457 · Cited by 586
Chae, J. J., Cho, Y.-H., Lee, G.-S., Cheng, J., Liu, P. P., Feigenbaum, L., Katz, S. I., & Kastner, D. L. (2011) · Immunity · doi:10.1016/j.immuni.2011.02.020 · Cited by 471
The Pyrin Inflammasome in Health and Disease
Schnappauf, O., Chae, J. J., Kastner, D. L., & Aksentijevich, I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01745 · Cited by 353
Metadata
- Authors
- Lachmann, H. J., Şengül, B., Yavuzşen, T. U., Booth, D. R., Booth, S. E., Bybee, A., Gallimore, J. R., Soytürk, M., Akar, S., Tunca, M., & Hawkins, P. N.
- Venue
- Rheumatology
- Publisher
- Oxford University Press (OUP)
- Published
- 2006-01-10
- Volume
- 45
- Issue
- 6
- Pages
- 746-750
- ISSN
- 1462-0324 (ISSN-L)
- 1462-0332
- OpenAlex
- W2122605756
- Cited by
- 386
- References
- 22
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. https://app.cochat.ai/papers/10.1093/rheumatology/kei279
- The paper
- Lachmann, H. J., Şengül, B., Yavuzşen, T. U., Booth, D. R., Booth, S. E., Bybee, A., Gallimore, J. R., Soytürk, M., Akar, S., Tunca, M., & Hawkins, P. N. (2006). Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology. https://doi.org/10.1093/rheumatology/kei279
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.